Authors: R. Popovtzer, A. Agrawal, M. Shlomi, A. Popovtzer, J. Balter, T.E. Carey, R. Kopelman
Affilation: University of Michigan, United States
Pages: 5 - 7
Keywords: molecular imaging, nanoparticles, contrast agents, CT
This research describes a new class of immuno-targeted and cancer specific CT contrast agents, which enable CT imaging of cancer at cellular and molecular resolution. The method is based on the development of gold nano-probes that specifically and sensitively target in vivo tumor specific antigens, while inducing distinct contrast in CT imaging (increased x-ray attenuation). The overall goal of this research is to develop a novel cancer imaging tool, which may lead to improvements in therapy due to early detection, accurate staging and micro-tumor identification.
Nanotech Conference Proceedings are now published in the TechConnect Briefs